Key Points:

• Monday’s calendar lists 10 expected pricing events, but most are ETFs or investment products, making the headline volume less representative of conventional operating-company IPO activity.
• GOWell Energy Technology is the most significant corporate-market event on the schedule, beginning Nasdaq trading after completing its business combination with Inflection Point Acquisition Corp. V.
• The pipeline becomes more consequential later in the week, with Oura and Accelevation preparing offerings that could provide a clearer test of investor demand for growth and technology-related companies.

Calendar Volume Masks a Thin Conventional IPO Session

The U.S. IPO calendar opens the week with 10 expected pricing events on September 28, but the composition is more important than the headline count. Seven of the listed securities are ETFs or investment vehicles, including products from The Arbitrage Funds, DFA Investment Dimensions Group and Putnam ETF Trust. The two corporate names, GOWell Energy Technology and Gentherm, also represent transactions that differ materially from a conventional primary IPO. The result is a market with substantial listing activity but relatively limited evidence of fresh operating-company issuance.

GOWell Brings a SPAC Combination to Nasdaq

GOWell Energy Technology is scheduled to begin trading on Nasdaq under GOW after completing its business combination with Inflection Point Acquisition Corp. V on September 25. The transaction is therefore better viewed as a de-SPAC listing than a traditional IPO, although it appears on the broader IPO calendar. Nasdaq confirmed the combined company’s listing effective September 28.

GOWell develops well-logging technologies, distributed sensing systems, software and data-interpretation services for energy companies, with applications spanning conventional oil and gas and emerging areas such as geothermal projects. The company says its operations and support network extend across more than 50 countries.

The transaction originally carried a proposed enterprise value of approximately $401.4 million, alongside a planned $70 million PIPE financing. Subsequent transaction documents showed changes to the capitalization structure, reinforcing why the completed transaction and current public-market valuation will matter more than the original headline deal terms.

Gentherm’s Listing Reflects a Corporate Transaction, Not New IPO Supply

Gentherm’s THRMV entry is another example of why calendar counts require careful interpretation. Nasdaq has established a when-issued market for shares of Gentherm that will be issued to Modine Manufacturing shareholders as part of the planned combination involving Modine’s Performance Technologies business. THRMV is scheduled to begin trading September 28 and continue through October 1, with settlement scheduled for October 5.

The underlying transaction is structured as a Reverse Morris Trust rather than a conventional capital-raising IPO. Gentherm shareholders have already approved the combination, while the transaction is expected to close October 1 subject to remaining conditions. Gentherm has also declared a conditional special cash dividend of approximately $1.90 per existing share.

ETF Activity Dominates the Headline Count

The seven ETF and investment-product entries illustrate the increasing importance of exchange-traded products in the daily listing calendar. ARB and EVNT represent The Arbitrage Funds, while DCOR, DFAR, DFSV, DUHP and DXUV are associated with DFA Investment Dimensions Group; PFRX is listed under Putnam ETF Trust.

These launches expand the number of securities entering U.S. markets, but they do not carry the same capital-formation implications as a conventional IPO in which an operating company raises equity from public investors. For the broader IPO market, the distinction matters because listing volume can increase without indicating a comparable improvement in traditional IPO issuance.

Larger IPO Tests Arrive Later in the Week

The more important test of investor demand comes on September 30, when Oura and Accelevation are expected to price. Oura’s preliminary prospectus calls for 50 million shares at $40 to $44, with the offering including both company shares and shares sold by existing stockholders.

Accelevation is pursuing a 30 million-share offering at $20 to $24, implying approximately $660 million at the midpoint. The data-center infrastructure company has reported rapid revenue growth and is positioning its business around power distribution, cooling and infrastructure for large-scale data-center deployments.

The IPO Window Faces Its Next Test

The September 28 calendar demonstrates that U.S. equity issuance remains active, but the underlying activity is highly selective and structurally diverse. The more meaningful signal will come from the pricing and aftermarket performance of Oura and Accelevation, where investors will be asked to establish valuations for sizable growth-oriented offerings. Their reception should provide a clearer indication of how much risk capital the public market is prepared to absorb as the third quarter closes.